Published in Blood Weekly, February 1st, 2007
"We are pleased that Quest Diagnostics has chosen the development of this PAD diagnostic test as the second of three programs that we will jointly develop," said Gail S. Page, president and CEO of Ciphergen. "The first program under our strategic alliance, an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.